Chinas Commerce Minister Skips APEC Opening on Urgent Official Business Trade Representative Calls for Cooperation Pentagon Releases Decades of UFO Reports Implications for Defense Sector Under Scrutiny Trump Urges Bank of America and JPMorgan to End Alleged Discrimination Against Conservatives Charter Communications Acquires Liberty Broadband in Improved Buyout Deal Economic Impact of Trump Tariffs Under Scrutiny Insights from Tax Foundation Moodys Corporation Analyst Sentiment What Wall Street Thinks About MCO Stock VEON Q1 2026 Earnings EPS Surpasses Estimates as Digital Transformation Gains Traction Nexa Resources Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Murphy USA MUSA Q1 2026 Earnings Strong EPS Beat of 415 Drives Investor Focus on Operational Efficiency AMT Q1 2026 Earnings EPS Beats Estimates by 1363 as Tower Operator Shows Resilience Kaiser Aluminum Q1 2026 Earnings Massive EPS Beat Drives Shares Higher DCBO Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Slips Slightly Where Food Comes From WFCF Slides 334 Key Support and Resistance Levels in Focus Ispire Technology ISPR Slides 791 as Shares Test Key Support Near 171 PBF Energy Inc PBF Gains 292 as Shares Approach Key Resistance Level Eaton Vance TaxManaged BuyWrite Opportunities Fund ETV Edges Lower Key Levels in Focus Neuphoria Therapeutics NEUP Soars 7 Key Levels to Watch After Bullish Breakout Morrisons to Close 100 Stores Amid Rising Cost Pressures JYNT Q1 2026 Earnings EPS Smashes Estimates by 141 as Shares Tick Higher Weyco Group WEYS Inches Upward as Shares Consolidate Near Key Thresholds PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent MacroGenics MGNX Q1 2026 Earnings Narrowing Loss on EPS Surprise as Stock Rebounds Arm Holdings Q1 2026 Earnings EPS Beat Drives Positive Market Reaction HBANL Q1 2026 Earnings Preferred Shares Edge Up Despite Significant EPS Miss HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Discretion MRAM Q1 2026 Earnings Earnings Per Share Beats Analyst Estimates by 19 Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly